Statement: There was less than 24hrs difference in Mean Duration of Grade 4 Neutropenia During Cycle 1 of Chemotherapy for the two arms of the primary trial.
Primary_evidence: Outcome Measurement:    Mean Duration of Grade 4 Neutropenia During Cycle 1 of Chemotherapy   Mean duration of severe neutropenia, defined as the mean number of consecutive days with Grade 4 neutropenia (ANC less than 0.5*10^9 cells/L)   Time frame: 21 days (Cycle 1 of chemotherapy treatment) Results 1:    Arm/Group Title: EP2006 + EP2006 & Neupogen   Arm/Group Description: All subjects randomized to receive either EP2006 in Cycle 1   Overall Number of Participants Analyzed: 101   Mean (Standard Deviation)   Unit of Measure: Days  1.17         (1.11) Results 2:    Arm/Group Title: Neupogen + Neupogen & EP2006   Arm/Group Description: All subjects randomized to receive Neupogen in Cycle 1   Overall Number of Participants Analyzed: 103   Mean (Standard Deviation)   Unit of Measure: Days  1.2         (1.02)